L-Asparaginase Injection 5,000 IU
| Product Overview | |
| Generic Name | L-Asparaginase Injection 5,000 IU |
| Brand Name(s) | Leunase, Elspar |
| Product Type | Generic |
| Form | Vial, Sterile lyophilised powder for injection |
| Strength | 5,000 IU per vial |
| Therapeutic Class | Antineoplastic enzyme preparation / other antineoplastic agent; |
| ATC Code | L01XX02 |
| Manufacturing & Regulatory | |
| Country | Mexico, India, USA, Canada |
| GMP Compliance | WHO-GMP |
| COFEPRIS | Registro Sanitario 158M88, no clave |
| Free Sale Certificate | Yes, available as COPP/CPP |
| Logistics & Export | |
| MOQ | 10 Units |
| Shelf Life | 24 Months |
| Storage | Refrigerated (2–8 °C) |
| Incoterms | EXW, 30049047 |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
| CTD Summary | CTD proprietary; available under commercial agreement/license |
Description
L-Asparaginase is an antineoplastic enzyme used as a component of multi-agent chemotherapy regimens, principally for acute lymphoblastic leukemia/acute lymphocytic leukemia and, in some protocols, lymphoblastic lymphoma. It acts by hydrolysing circulating asparagine, thereby depriving lymphoblasts of an amino acid required for protein synthesis and cellular proliferation.
